Cascade/dCas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells
US11008557B1 · kind B1 · utility
5Cited by
18References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 15, 2020 |
| Grant date | May 18, 2021 |
| Priority date | — |
| Expiry date | Dec 15, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2800/80
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present disclosure relates to methods and compositions that allow one to identify in vivo edited cells when employing nucleic-acid guided editing. Additionally provided are automated multi-module instruments for performing editing and selection methods and using the compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.